Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000897587 | SCV001041740 | likely benign | Ataxia-telangiectasia syndrome | 2024-11-04 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225765 | SCV002504787 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255572 | SCV002530481 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-02 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004588321 | SCV005084157 | likely benign | Familial cancer of breast | 2024-06-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Natera, |
RCV000897587 | SCV001452138 | uncertain significance | Ataxia-telangiectasia syndrome | 2020-03-17 | no assertion criteria provided | clinical testing |